WO2023026160 - METHOD AND SYSTEM TO NON-INVASIVELY ASSESS ELEVATED LEFT VENTRICULAR END-DIASTOLIC PRESSURE
National phase entry:
Publication Number
WO/2023/026160
Publication Date
02.03.2023
International Application No.
PCT/IB2022/057812
International Filing Date
19.08.2022
Title **
[English]
METHOD AND SYSTEM TO NON-INVASIVELY ASSESS ELEVATED LEFT VENTRICULAR END-DIASTOLIC PRESSURE
[French]
PROCÉDÉ ET SYSTÈME POUR ÉVALUER DE MANIÈRE NON INVASIVE UNE PRESSION DIASTOLIQUE D'EXTRÉMITÉ VENTRICULAIRE GAUCHE ÉLEVÉE
Applicants **
ANALYTICS FOR LIFE INC.
160 Bloor Street East
Suite 910
Toronto, Ontario M4W 1B9, CA
Inventors
BURTON, Timothy William Fawcett
573 Evered Street
Toronto, Ontario K17 5L1, CA
RAMCHANDANI, Shyamlal
82 Beverley St.
Kingston, Ontario K7L 3Y6, CA
KHOSOUSI, Ali
GV 203 - 38 Kenaston Gardens
North York, Ontario M2K 1G8, CA
FATHIEH, Farhad
83 Waterloo Ave
North York, Ontario M3H 3Y3, CA
FIROUZI, Mohammad
401-77 Roehampton Ave.
Toronto, Ontario M4P 3B8, CA
LANGE, Emmanuel
35 Notley Place
Toronto, Ontario M48 2M7, CA
DOOMRA, Abhinav
25 Oliti Ct
North York, Ontario M9L 3A3, CA
Priority Data
63/235,960
23.08.2021
US
63/235,963
23.08.2021
US
63/235,966
23.08.2021
US
63/235,968
23.08.2021
US
63/235,971
23.08.2021
US
63/235,974
23.08.2021
US
63/236,072
23.08.2021
US
63/236,193
23.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| Sequence Listing | * |
| International Search Report is established | *
International Searching Authority
CIPO
* |
| Applicant's Legal Status |
Legal Entity
* * * * * |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2895 | |
| EPO | Filing, Examination | 24057 | |
| Japan | Filing | 560 | |
| South Korea | Filing | 811 | |
| USA | Filing, Examination | 10435 |
Total: 38758 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A clinical evaluation system and method are disclosed that facilitate the use of features or parameters extracted from biophysical signals in a model or classifier (e.g., a machine-learned classifier) to estimate metrics associated with the physiological state of a patient, including for the presence or non-presence of elevated left ventricular end-diastolic pressure (elevated LVEDP), as an example indicator of a disease medical condition that could be assessed by using the system and method described herein.[French]
L'invention concerne un système et un procédé d'évaluation clinique qui permettent de faciliter l'utilisation de caractéristiques ou de paramètres extraits de signaux biophysiques dans un modèle ou un classificateur (par exemple, un classificateur appris par machine) pour estimer des métriques associées à l'état physiologique d'un patient, notamment pour la présence ou l'absence d'une pression diastolique d'extrémité ventriculaire gauche élevée (LVEDP élevée), en tant qu'indicateur donné à titre d'exemple d'un état pathologique médical qui pourrait être évalué à l'aide du système et du procédé présentement décrits.